ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014